Prime Medicine, Inc.

PRME

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001894562

SEC filings (opens in a new tab)

No open-market purchases or sales by Prime Medicine, Inc. insiders were filed in the last 90 days; 187 institutions reported holding it in 13F filings for Q2 2026, worth $393.5M in total; ARK Invest is the only superinvestor holding it.

Q1 2024 vs. Q4 2023

How the institutions holding Prime Medicine, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of PRME: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Q1 2024	Change
Holders	105	115	+10
Shares	48.7M	66.7M	+18.0M (+36.9%)
Value	$431.4M	$466.6M	+$35.1M (+8.1%)

New holders (23)

Institutions that held Prime Medicine, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to PRME in Q1 2024
Institution	Shares	Value	% of portfolio
T. Rowe Price Investment Management, Inc.	3,090,083	$21.6M	0.01%
Avidity Partners Management LP	1,990,000	$13.9M	0.50%
Farallon Capital Management, L.L.C.	750,000	$5.25M	0.03%
EcoR1 Capital, LLC	700,000	$4.90M	0.12%
Moore Capital Management, LP	500,000	$3.50M	0.07%
Schonfeld Strategic Advisors LLC	330,500	$2.31M	0.02%
Deep Track Capital, LP	303,716	$2.13M	0.06%
Westwood Holdings Group Inc.	159,351	$1.11M	0.01%
Citadel Advisors LLC	108,198	$757.4K	0.00%
Tudor Investment Corp Et Al	61,295	$429.1K	0.01%
Cinctive Capital Management LP	33,033	$231.2K	0.01%
Verition Fund Management LLC	29,515	$206.6K	0.00%
Cornercap Investment Counsel Inc	29,241	$204.7K	0.03%
D. E. Shaw & Co., Inc.	26,668	$186.7K	0.00%
Susquehanna Fundamental Investments, LLC	21,175	$148.2K	0.01%
Invesco Ltd.	10,611	$74.3K	0.00%
Simplex Trading, LLC	4,837	$33.0K	0.00%
Federated Hermes, Inc.	3,576	$25.0K	0.00%
Benjamin F. Edwards & Company, Inc.	427	$3.00K	0.00%
Avion Wealth	71	$1.00K	0.00%
Riggs Asset Managment Co. Inc.	36	$252	0.00%
Farther Finance Advisors, LLC	26	$176	0.00%
Abich Financial Wealth Management LLC	24	$168	0.00%

Sold out (13)

Institutions that held Prime Medicine, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of PRME in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Woodline Partners LP	120,060	$1.06M
Trexquant Investment LP	26,983	$239.1K
Mirae Asset Global Investments Co., Ltd.	21,301	$188.7K
Gsa Capital Partners LLP	12,195	$108.0K
Amundi	11,770	$106.0K
State Board of Administration of Florida Retirement System	11,420	$101.2K
Y-Intercept (Hong Kong) Ltd	10,193	$90.3K
SG Americas Securities, LLC	10,128	$90.0K
ORG Partners LLC	5,270	$46.7K
Advisory Services Network, LLC	1,153	$10.2K
Sandia Investment Management LP	1,084	$9.60K
Glassman Wealth Services	103	$913
GAMMA Investing LLC	118	$749